Statistics
Publications
22
Citations
1.2K
H-Index
18
Active since
2008
Ilkka Liikanen is an author at University of Helsinki specializing in oncology, medicine, and cancer immunotherapy.
Publications per year
2008–2022
22
22
Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy
Ilkka Liikanen, Anniina Koski, Maiju Merisalo-Soikkeli et al. · OncoImmunology · 2015 · 59 citations · Full text
Medicine, Immunology, Oncology +17
1–5 of 22